Alnylam Pharmaceuticals
ALNY
#696
Rank
NZ$62.56 B
Marketcap
NZ$468.64
Share price
1.13%
Change (1 day)
-13.15%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company